跳至主要内容
临床试验/JPRN-UMIN000053658
JPRN-UMIN000053658尚未招募Unknown

Randomized, double-blind, placebo-controlled parallel-group comparative study to evaluate the efficacy of the peptide on reducing body fat - Clinical study to evaluate the efficacy of the peptide on reducing body fat

Yamaguchi Health Lab0 个研究点目标入组 100 人开始时间: 2024年2月25日最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 65years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Subjects who have serious disease or who have history of serious disease 2) Subjects who regularly undertake medications that affect obesity, hyperlipidemia or lipid metabolism 3) Subjects who cannot stop taking health foods or supplements that affect obesity, hyperlipidemia or lipid metabolism 4) Heavy smokers (more than 21 cigarettes/day) 5) Subjects who have excessive alcoholic drinks (more than 60 g/day of alcohol) 6) Subjects with serious medication allergy or food allergy 7) Subject who is pregnant or under lactation, or who is expected to be pregnant during the study 8) Subjects who are currently participating, or intend to participate during this study period, in other trials involving the testing of other foods or the use of drugs or the application of cosmetics and drugs 9) Subjects who are considered to be inappropriate for this study by the principal investigator or the examination doctor

研究者

发起方
Yamaguchi Health Lab

相似试验